GLANZMAN ROBERTdirector: Chief Medical Officerdirector: Chief Medical Officer
Common Stock
4,717
$2.03
$9,576
Purchase
GAY JONATHONdirector: director:
Common Stock
10,000
$2.08
$20,800
Option
WILCOX REED Ndirector: director:
Stock Options (Right to buy)
100,000
N/A
N/A
Sale
GENERAL RESONANCE LLCdirector: director:
Common Stock
132,891
$3.01
$400,002
Purchase
MATLIN DAVID Jdirector: director:
Common Stock
132,891
$3.01
$400,002
Purchase
MATLIN DAVID Jdirectordirector
Common Stock
8,648
$3.23
$27,933
Purchase
MATLIN DAVID Jdirectordirector
Common Stock
10,000
$3.1
$31,000
Purchase
MATLIN DAVID Jdirectordirector
Common Stock
20,000
$2.99
$59,800
Purchase
MATLIN DAVID Jdirectordirector
Common Stock
20,000
$2.94
$58,800
Purchase
MATLIN DAVID Jdirectordirector
Common Stock
35,000
$2.9
$101,500
Purchase
MATLIN DAVID Jdirectordirector
Common Stock
20,000
$2.79
$55,800
Option
STEVENS JOHN HENRYdirectordirector
Stock Options (Right to buy)
273,194
$0.53
$144,793
Option
STEVENS JOHN HENRYdirectordirector
Common Stock
273,194
$0.53
$144,793
Sale
GENERAL RESONANCE LLC10 percent owner10 percent owner
Common Stock
101,352
$2.96
$300,002
Showing 1 to 50 of 61 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.